93 results
DRSLTR
NVRO
Nevro Corp
16 Sep 14
Correspondence regarding draft registration statement
12:00am
provided under Rule 3a-8 under the 40 Act for research and development companies.
After giving effect to the offering contemplated by Submission No. 2 … on the Company’s satisfaction of the seven requirements of the Rule, as set forth below.
(1) Substantial Research and Development Expenses. A company’s research
10-Q
2014 Q3
NVRO
Nevro Corp
2 Dec 14
Quarterly report
12:00am
September 30,
Revenue
Cost of revenue
Gross profit
Operating expenses
Research and development
Sales, general and administrative
Total operating expenses … loss and have been presented in the consolidated statements of operations and comprehensive loss.
Research and Development
Research and development
S-1/A
EX-10.17
fbshdzhr
10 Oct 14
IPO registration (amended)
12:00am
8-K
EX-99.1
2rn8kjvw xskos2jv8ao
2 Mar 15
Nevro Appoints Dr. Brad Vale to its Board of Directors
12:00am
10-K
ay3gt87
18 Mar 15
Annual report
12:00am
8-K
EX-99.1
laa kqwue8
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
424B4
i0uuxx4i
6 Nov 14
Prospectus supplement with pricing info
12:00am
S-1
eqfmo18isrouad
3 Oct 14
IPO registration
12:00am